Suppr超能文献

B 细胞特征决定 HCV 再感染结局。

B-cell characteristics define HCV reinfection outcome.

机构信息

School of Biomedical Science, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

School of Biomedical Science, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.

出版信息

J Hepatol. 2024 Sep;81(3):415-428. doi: 10.1016/j.jhep.2024.04.004. Epub 2024 Apr 10.

Abstract

BACKGROUND & AIMS: In individuals highly exposed to HCV, reinfection is common, suggesting that natural development of sterilising immunity is difficult. In those that are reinfected, some will develop a persistent infection, while a small proportion repeatedly clear the virus, suggesting natural protection is possible. The aim of this study was to characterise immune responses associated with rapid natural clearance of HCV reinfection.

METHODS

Broad neutralising antibodies (nAbs) and Envelope 2 (E2)-specific memory B cell (MBC) responses were examined longitudinally in 15 individuals with varied reinfection outcomes.

RESULTS

Broad nAb responses were associated with MBC recall, but not with clearance of reinfection. Strong evidence of antigen imprinting was found, and the B-cell receptor repertoire showed a high level of clonality with ongoing somatic hypermutation of many clones over subsequent reinfection events. Single-cell transcriptomic analyses showed that cleared reinfections featured an activated transcriptomic profile in HCV-specific B cells that rapidly expanded upon reinfection.

CONCLUSIONS

MBC quality, but not necessarily breadth of nAb responses, is important for protection against antigenically diverse variants, which is encouraging for HCV vaccine development.

IMPACT AND IMPLICATIONS

HCV continues to have a major health burden globally. Limitations in the health infrastructure for diagnosis and treatment, as well as high rates of reinfection, indicate that a vaccine that can protect against chronic HCV infection will greatly complement current efforts to eliminate HCV-related disease. With alternative approaches to testing vaccines, such as controlled human inoculation trials under consideration, we desperately need to identify the correlates of immune protection. In this study, in a small but rare cohort of high-risk injecting drug users who were reinfected multiple times, breadth of neutralisation was not associated with ultimate clearance of the reinfection event. Alternatively, characteristics of the HCV-specific B-cell response associated with B-cell proliferation were. This study indicates that humoral responses are important for protection and suggests that for genetically very diverse viruses, such as HCV, it may be beneficial to look beyond just antibodies as correlates of protection.

摘要

背景与目的

在高度暴露于 HCV 的个体中,再感染很常见,这表明难以自然产生有效的免疫。在再感染者中,有些人会发展为持续性感染,而一小部分人则会反复清除病毒,这表明自然保护是可能的。本研究旨在描述与 HCV 再感染快速自然清除相关的免疫反应。

方法

对 15 例具有不同再感染结果的个体进行了广泛中和抗体(nAb)和包膜 2(E2)特异性记忆 B 细胞(MBC)反应的纵向研究。

结果

广泛的 nAb 反应与 MBC 回忆有关,但与再感染的清除无关。发现了强烈的抗原印记证据,B 细胞受体库显示出高水平的克隆性,并且在随后的再感染事件中许多克隆都发生了持续的体细胞超突变。单细胞转录组分析显示,清除的再感染具有 HCV 特异性 B 细胞的激活转录组谱,这些细胞在再感染后迅速扩增。

结论

MBC 的质量,而不是 nAb 反应的广度,对于对抗抗原多样化的变体很重要,这对 HCV 疫苗的开发是令人鼓舞的。

影响和意义

HCV 仍然在全球范围内造成重大健康负担。诊断和治疗的卫生基础设施的局限性以及高再感染率表明,一种能够预防慢性 HCV 感染的疫苗将极大地补充目前消除 HCV 相关疾病的努力。随着替代疫苗测试方法的考虑,例如正在考虑的受控人体接种试验,我们迫切需要确定免疫保护的相关因素。在这项研究中,在一个较小但风险较高的注射吸毒者再感染多次的罕见队列中,中和的广度与再感染事件的最终清除无关。相反,与 B 细胞增殖相关的 HCV 特异性 B 细胞反应的特征与 B 细胞增殖有关。这项研究表明,体液反应对于保护很重要,并表明对于遗传上非常多样化的病毒,如 HCV,除了抗体之外,寻找保护相关因素可能是有益的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验